Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CholeraGarde in HIV-seropositive adults
NCT00741637Phase 2Completed
- Sponsor
- International Vaccine Institute
- Start
- Jul 2010
- Primary completion
- Apr 2011
- Modality
- Split/Subunit Vaccines, Live Attenuated Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Peru-15 vaccine in cholera, sponsored by International Vaccine Institute. Started Jul 2010; status: completed.
02
Drugs
Peru-15 vaccine
03
Conditions
cholera
Beyond the preview
Go deeper on NCT00741637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00741637.